Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-145545

Principal Accounting Officer acquired 4,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bowen Matthew Principal Accounting Officer 2026-04-06 Grant or award +4,300 25,904 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Bowen Matthew Principal Accounting Officer 2026-04-06 Grant or award · Stock Option (Right to Buy) +19,500 19,500 D: show line 2 in the form
Loading xslF345X06/ownership.xml…